Carole A. Sable
Chief Tech/Sci/R&D Officer at VITAE PHARMACEUTICALS INC
Carole A. Sable active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VITAE PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 2016-06-05 | - |
| BASILEA PHARMACEUTICA AG | Director/Board Member | 2023-04-26 | - |
Career history of Carole A. Sable
Former positions of Carole A. Sable
| Companies | Position | Start | End |
|---|---|---|---|
| SCYNEXIS, INC. | Chief Tech/Sci/R&D Officer | 2013-12-31 | 2015-02-19 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2009-12-31 | 2012-12-31 |
| MERCK & CO., INC. | Corporate Officer/Principal | 1994-12-31 | 2006-12-31 |
| University of Virginia | Corporate Officer/Principal | 1992-12-31 | 1994-12-31 |
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 2015-03-04 | - |
Novexel SA
 Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Chief Tech/Sci/R&D Officer | - | - |
Training of Carole A. Sable
| Sidney Kimmel Medical College | Doctorate Degree |
| Thomas Jefferson University | Doctorate Degree |
Statistics
International
| United States | 8 |
| France | 2 |
| Switzerland | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| BASILEA PHARMACEUTICA AG | Health Technology |
| Private companies | 2 |
|---|---|
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Health Technology |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
- Stock Market
- Insiders
- Carole A. Sable
- Experience
